Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn

June 06, 2022 10:08 AM PDT | By Mridul Gogoi
Follow us on Google News:


  • Becton, Dickinson & Company or BD (NYSE: BDX) to acquire Parata Systems for US$1.525 billion.
  • The deal is likely to close by the end of the first half of fiscal 2023 for BD.
  • The pharmacy automation market is set to grow approximately 10% yearly to US$1.5 billion over the next years in the US.

Becton, Dickinson and Company or BD (NYSE: BDX) revealed on Monday that it would take over Parata Systems in an all-cash US$1.525 billion deal.

Medical technology company BDX has reached a definitive agreement to acquire Parata Systems, the innovative provider of pharmacy automation solutions company.   

Supporting a growing network of pharmacies, Parata Systems’ core competencies include reducing costs, enhancing patient safety, and improving patient experience.

With its innovative pharmacy automation solutions, Parata will provide Becton, Dickinson & Company access to a new US$600 million pharmacy automation market segment.

The pharmacy automation systems market has witnessed robust growth in recent years due to a breakout of various diseases and a call for thwarting prescription and dispensing anomalies.

Also Read: World Environment Day: Green investments that can earn you some green

Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn© Designer491 |

Also Read: ADBE to CRM: Five top SaaS stocks to explore in June

Acquisition of Parata Systems to bolster BD

The pharmacy automation market is set to grow approximately 10% yearly to US$1.5 billion over the next years in the US.

So, this acquisition deal will help BD grow and augment its strategies for the future.

The agreement will help increase BD’s transformative solutions for new pharmacy automation technologies in hospitals, pharmacies, care centers, and home settings.

The proposed deal will encourage long-term strategies of BD to push for innovation in smart connected care and improve new care settings.

Becton expects the merger to generate and add to the revenue growth, adjusted operating margins, and adjusted EPS (earnings per share). The company is also hopeful that the deal will scale up the long-range sales and earnings growth profile.

Once the regulatory clearances come, and after fulfilling customary closing conditions, the deal will go through between BD and Parata Systems. It will likely be closed by the end of the first half of the fiscal year 2023 for BD.

Bottom line:

Becton, Dickinson deals in medical supplies, intervention devices, and other innovative products. It is also known for the first insulin syringe and blood collection tube.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

Top Listed Companies